Dr Tim Eckmanns
Biography
Head, Unit Healthcare-associated Infections, Surveillance of Antibiotic Resistance and Consumption Department Infectious Disease Epidemiology Robert Koch Institute, Berlin Germany
Dr Tim Eckmanns is trained as a medical doctor and is board-certified in infection control and environmental health. He also has a Master of Science in Epidemiology from the London School of Hygiene and Tropical Medicine and has a Master of Medical Computer Science (MCS) from the Berlin University of Applied Science. Tim Eckmanns is the head of the Division for healthcare-associated infections, surveillance of antimicrobial resistance and consumption at the Robert Koch Institute, the German national public health institute. His unit hosts the scientific secretariat of the commission for antiinfectives, resistance and therapy in Germany which is anchored in the German Protection against Infection Act and responsible for generic recommendations and policy advice on appropriate antibiotic use. In the years 2014 and 2015 for 11 months he was seconded to the World Health Organization working in the field of Ebola in Geneva and in Sierra Leone. He has wide-spread expertise in infectious disease epidemiology, outbreak investigation and evidence-based public health. Additional he has extensive experience in conceptualizing, developing, implementing and evaluating surveillance systems for antimicrobial resistance, antimicrobial consumption, and healthcare-associated infections at the national and international level. He is PI and partner in several national and international projects in the field of AMR and IPC, co-chair of the NDPHS AMR expert group and member of the coordinating committee of EARS-Net, and member of the ESCMID surveillance study group ESGARS. He is responsible for the AMR activities of the WHO Collaborating Centre for Emerging Infections and Biological Threats at RKI and his unit is coordinator of the WHO AMR Surveillance and Quality Assessment Collaborating Centres Network. He is first and co-author of more than 150 publications in the field of infectious diseases surveillance, outbreak investigation, AMR, and IPC.